Jeffrey M. Jonas's Insider Trades & SAST Disclosures
Jeffrey M. Jonas's most recent trade in Sage Therapeutics Inc was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 10, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeffrey M. Jonas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 13,810 | 33,702 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 01 Aug 2023 | 13,810 | 14,800 (0%) | 0% | 7.3 | 100,399 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 195.61 per share. | 01 Aug 2023 | 6,301 | 5,100 (0%) | 0% | 195.6 | 1,232,539 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 194.78 per share. | 01 Aug 2023 | 3,399 | 11,401 (0%) | 0% | 194.8 | 662,057 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 196.59 per share. | 01 Aug 2023 | 3,110 | 1,990 (0%) | 0% | 196.6 | 611,395 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 198.41 per share. | 01 Aug 2023 | 600 | 990 (0%) | 0% | 198.4 | 119,046 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 197.66 per share. | 01 Aug 2023 | 400 | 1,590 (0%) | 0% | 197.7 | 79,064 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 13,810 | 47,512 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 03 Jul 2023 | 13,810 | 14,800 (0%) | 0% | 7.3 | 100,399 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 215.91 per share. | 03 Jul 2023 | 7,966 | 6,600 (0%) | 0% | 215.9 | 1,719,939 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 216.78 per share. | 03 Jul 2023 | 3,201 | 3,399 (0%) | 0% | 216.8 | 693,913 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 217.82 per share. | 03 Jul 2023 | 2,409 | 990 (0%) | 0% | 217.8 | 524,728 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 214.61 per share. | 03 Jul 2023 | 234 | 14,566 (0%) | 0% | 214.6 | 50,219 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 1,904 | 1,904 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 990 | 990 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 10 Feb 2023 | 11,643 | 133,624 (0%) | 0% | 0.4 | 5,239 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 11,643 | 0 | - | - | Stock Options (Right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 44.47 per share. | 10 Feb 2023 | 7,805 | 125,819 (0%) | 0% | 44.5 | 347,084 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Sale of securities on an exchange or to another person at price $ 44.90 per share. | 10 Feb 2023 | 3,838 | 121,981 (0%) | 0% | 44.9 | 172,329 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 5,100 | 123,408 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.16 per share. | 03 Feb 2023 | 1,427 | 121,981 (0%) | 0% | 44.2 | 63,016 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 2,501 | 57,499 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.63 per share. | 03 Jan 2023 | 2,501 | 118,308 (0%) | 0% | 28.6 | 71,604 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,000 | 5,000 | - | - | Option (right to buy) | |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,200 | 19,200 | - | - | Stock Option (right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 30,944 | 11,643 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 27 Apr 2022 | 30,944 | 115,807 (0%) | 0% | 0.5 | 13,925 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 17 Feb 2022 | 4,000 | 84,863 (0%) | 0% | 0.5 | 1,800 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 4,000 | 42,587 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 10,000 | 85,237 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.29 per share. | 19 Oct 2021 | 4,374 | 80,863 (0%) | 0% | 40.3 | 176,228 | Common Stock |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 8,500 | 8,500 | - | - | Option (right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 15 Jun 2021 | 12,000 | 75,237 (0%) | 0% | 0.5 | 5,400 | Common Stock |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 12,000 | 46,587 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 10,000 | 66,330 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.80 per share. | 15 Jun 2021 | 3,093 | 63,237 (0%) | 0% | 58.8 | 181,868 | Common Stock |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 1,800 | 58,587 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Jeffrey M. Jonas | Director, Chief Innovation Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 27 Jan 2021 | 1,800 | 56,330 (0%) | 0% | 0.5 | 810 | Common Stock |
| Generation Bio Co | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 52,000 | 52,000 | - | - | Stock Option (right to buy) | |
| Karuna Therapeutics Inc | Jeffrey M. Jonas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 12,500 | 12,500 | - | - | Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges